Chorda Pharma Selected for Commercialization Grant The Virginia Innovation Partnership Corporation (VIPC) has notified Chorda Pharma that it will receive a grant from the Commonwealth Commercialization Fund (CCF) for the Commercialization of a Non-Opioid Topical Analgesic. The $75,000 award will be used to help fund the testing, pilot manufacturing, and marketing of Capsadyn™, which offers
Category: Business & Industrial
Country: United States of America (US)
Platform: WooCommerce
Technologies used: Yoast
Contact page: https://chordapharma.com/contact-us
Signup for Free. No Credit Card required.Suitable for marketing agencies, app developers and new business ideas.
No credit card required.